These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8359180)

  • 21. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
    Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
    Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G; Ninci R; Della Corte L; Valoti M; Nardini M; Andreoli V; Moneti G
    Drug Metab Dispos; 1986; 14(2):263-6. PubMed ID: 2870904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
    Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
    Rivera-Calimlim L; Nasrallah H; Strauss J; Lasagna L
    Am J Psychiatry; 1976 Jun; 133(6):646-52. PubMed ID: 5901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma nor1-chlorpromazine concentrations: effects of age, race, and sex.
    Young RC
    Ther Drug Monit; 1986; 8(1):23-6. PubMed ID: 3961892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of endogenous levels of GHB in human hair. Are there possibilities for the identification of GHB administration through hair analysis in cases of drug-facilitated sexual assault?
    Goullé JP; Chèze M; Pépin G
    J Anal Toxicol; 2003; 27(8):574-80. PubMed ID: 14670136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats.
    Porter JH; Prus AJ; Vann RE; Varvel SA
    Psychopharmacology (Berl); 2005 Feb; 178(1):67-77. PubMed ID: 15316715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis.
    Miyazawa N; Uematsu T
    Ther Drug Monit; 1992 Dec; 14(6):525-8. PubMed ID: 1485377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of lithium on plasma chlorpromazine levels.
    Rivera-Calimlim L; Kerzner B; Karch FE
    Clin Pharmacol Ther; 1978 Apr; 23(4):451-5. PubMed ID: 630793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems in therapeutic blood monitoring of chlorpromazine.
    Rivera-Calimlim L
    Ther Drug Monit; 1982; 4(1):41-9. PubMed ID: 7041337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The measurement of ofloxacin in hair as an index of exposure.
    Uematsu T; Miyazawa N; Nakashima M
    Eur J Clin Pharmacol; 1991; 40(6):581-4. PubMed ID: 1884739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein binding of chlorpromazine in vivo and in vitro: effect of chlorpromazine metabolite on chlorpromazine protein binding in rat.
    Sato S; Koshiro A
    Biol Pharm Bull; 1995 Apr; 18(4):586-92. PubMed ID: 7655433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.
    Alfredsson G; Wode-Helgodt B; Sedvall G
    Psychopharmacology (Berl); 1976 Jul; 48(2):123-31. PubMed ID: 826923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of temafloxacin in human scalp hair as an index of drug exposure.
    Uematsu T; Kondo K; Yano S; Yamaguchi T; Umemura K; Nakashima M
    J Pharm Sci; 1994 Jan; 83(1):42-5. PubMed ID: 8138908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of radioimmunoassay for chlorpromazine.
    Kawashima K; Dixon R; Spector S
    Eur J Pharmacol; 1975; 32(02):195-202. PubMed ID: 1149806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporation of zolpidem and methoxyphenamine into white hair strands after single administrations: Influence of hair pigmentation on drug incorporation.
    Shima N; Nitta A; Kamata T; Sasaki K; Matsuta S; Ishikawa A; Asai R; Wada M; Kakehashi H; Nakano S; Kamata H; Sato T; Tsuchihashi H; Miki A; Katagi M
    Forensic Sci Int; 2019 Aug; 301():67-75. PubMed ID: 31129374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.